SMN dosage analysis and risk assessment for spinal muscular atrophy.
- 1 June 2002
- journal article
- Published by Elsevier in American Journal of Human Genetics
- Vol. 70 (6) , 1596-1598
- https://doi.org/10.1086/340789
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Genetic risk assessment in carrier testing for spinal muscular atrophyAmerican Journal of Medical Genetics, 2002
- Spinal Muscular Atrophy Genetic Testing Experience at an Academic Medical CenterThe Journal of Molecular Diagnostics, 2002
- Quantitative Analyses of SMN1 and SMN2 Based on Real-Time LightCycler PCR: Fast and Highly Reliable Carrier Testing and Prediction of Severity of Spinal Muscular AtrophyAmerican Journal of Human Genetics, 2002
- Heteroduplex Formation in SMN Gene Dosage AnalysisThe Journal of Molecular Diagnostics, 2001
- Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extensionHuman Mutation, 2000
- SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletionEuropean Journal of Human Genetics, 2000
- Quantitative Analysis of Survival Motor Neuron Copies: Identification of Subtle SMN1 Mutations in Patients with Spinal Muscular Atrophy, Genotype-Phenotype Correlation, and Implications for Genetic CounselingAmerican Journal of Human Genetics, 1999
- When Is a Deletion Not a Deletion? When It Is ConvertedAmerican Journal of Human Genetics, 1997
- Identification of Proximal Spinal Muscular Atrophy Carriers and Patients by Analysis of SMNT and SMNC Gene Copy NumberAmerican Journal of Human Genetics, 1997
- Natural History in Proximal Spinal Muscular AtrophyArchives of Neurology, 1995